These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 5439551)
21. [The addition of amantadine to prolonged treatment with L-Dopa. Considerations on 20 cases]. Giuffrè R; Gambacorta D Minerva Med; 1971 Oct; 62(82):4009-12. PubMed ID: 5125066 [No Abstract] [Full Text] [Related]
22. Non-resting tremor in Parkinson's disease. Schwab RS; Young RR Trans Am Neurol Assoc; 1971; 96():305-7. PubMed ID: 5159117 [No Abstract] [Full Text] [Related]
23. [Clinical considerations on therapy of parkinsonian syndromes with amantadine and L-Dopa]. Ambrosetto C; Martinelli P Minerva Med; 1971 Oct; 62(82):4017-9. PubMed ID: 5125069 [No Abstract] [Full Text] [Related]
24. [Amantadine hydrochloride in the treatment of Parkinson's syndrome]. De la Herrán J; Figuerido JA Rev Esp Otoneurooftalmol Neurocir; 1971; 29(167):45-9. PubMed ID: 5091472 [No Abstract] [Full Text] [Related]
25. [Current therapeutic problems of the parkinson syndrome]. Völler GW; Kapp W Med Welt; 1971 Aug; 33():1280-2. PubMed ID: 5566844 [No Abstract] [Full Text] [Related]
26. [Preliminary observations on the use of intravenous amantadine and of the association of oral amantadine with anticholinergic drugs and with levo-dopa in the treatment of Parkinson's disease]. Fasano VA; Urciuoli R; Broggi G Minerva Med; 1970 Jul; 61(53):2895-903. PubMed ID: 5428170 [No Abstract] [Full Text] [Related]
28. [Amantadine in the treatment of transitory hypokinesia in patients with parkinsonism during therapy with L-Dopa]. De Divitiis E; D'Andrea F; Signorelli CD; Cerillo A Minerva Med; 1971 Oct; 62(82):4007-8. PubMed ID: 5125065 [No Abstract] [Full Text] [Related]
29. L-dopa and amantadine hydrochloride in Parkinson's disease. Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417 [No Abstract] [Full Text] [Related]
30. [Review of current pharmacotherapy of Parkinsonism. Comprehensive review]. Benesová O Cesk Neurol; 1973 May; 36(3):196-205. PubMed ID: 4574253 [No Abstract] [Full Text] [Related]
31. [Preliminary results of the use of amantadine in parkinsonian syndromes]. Montanari M; Monaco V; Robotti CA Minerva Med; 1971 Oct; 62(82):3955-7. PubMed ID: 5125050 [No Abstract] [Full Text] [Related]
32. L-dopa and amantadine for Parkinsonism. Drug Ther Bull; 1970 Aug; 8(17):65-7. PubMed ID: 5480244 [No Abstract] [Full Text] [Related]
33. [Therapeutic association of amantadine and L-Dopa in parkinsonism]. Signorelli CD; D'Andrea F; De Divitiis E; Cerillo A Minerva Med; 1971 Oct; 62(82):4015-6. PubMed ID: 5125068 [No Abstract] [Full Text] [Related]
34. Drug therapy of parkinsonism. Yahr MD; Duvoisin RC N Engl J Med; 1972 Jul; 287(1):20-4. PubMed ID: 4555145 [No Abstract] [Full Text] [Related]
35. [Conservative therapy in the Parkinson syndrome]. Birkmayer W Wien Med Wochenschr; 1971 Nov; 121(46):827-9. PubMed ID: 5138823 [No Abstract] [Full Text] [Related]
36. [Medical treatment of Parkinson's disease]. Castaigne P; Rondot P; Ribadeau-Dumas JL Ann Med Interne (Paris); 1972 Apr; 123(4):357-64. PubMed ID: 5077040 [No Abstract] [Full Text] [Related]
37. [Pathochemical bases for the treatment of parkinsonism]. Petelin LS; Tret'iakova KA; Pigarev VA; Romenskaia LK Zh Nevropatol Psikhiatr Im S S Korsakova; 1971 Dec; 71(12):1765-70. PubMed ID: 5143959 [No Abstract] [Full Text] [Related]
39. Amantadine hydrochloride in the treatment of Parkinsonism. A controlled trial. Appleton DB; Eadie MJ; Sutherland JM Med J Aust; 1970 Oct; 2(14):626-9. PubMed ID: 4920572 [No Abstract] [Full Text] [Related]
40. [Psychological status of patients with Parkinsonism during treatment with amantadine hydrochloride and L-Dopa]. Ferraris M Minerva Med; 1971 Oct; 62(82):3971-3. PubMed ID: 5125056 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]